Arrowhead Net Tangible Assets from 2010 to 2024
ARWR Stock | USD 24.88 0.21 0.85% |
Net Tangible Assets | First Reported 2011-06-30 | Previous Quarter 354.1 M | Current Value 261.1 M | Quarterly Volatility 169.7 M |
Check Arrowhead Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arrowhead main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 M, Interest Expense of 20 M or Selling General Administrative of 79.1 M, as well as many exotic indicators such as Price To Sales Ratio of 10.19, Dividend Yield of 0.0 or PTB Ratio of 4.8. Arrowhead financial statements analysis is a perfect complement when working with Arrowhead Pharmaceuticals Valuation or Volatility modules.
Arrowhead | Net Tangible Assets |
Latest Arrowhead Pharmaceuticals' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Arrowhead Pharmaceuticals over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Arrowhead Pharmaceuticals' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arrowhead Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
Timeline |
Arrowhead Net Tangible Assets Regression Statistics
Arithmetic Mean | 192,166,194 | |
Geometric Mean | 124,346,220 | |
Coefficient Of Variation | 74.76 | |
Mean Deviation | 118,228,608 | |
Median | 165,526,952 | |
Standard Deviation | 143,672,320 | |
Sample Variance | 20641.7T | |
Range | 436.4M | |
R-Value | 0.70 | |
Mean Square Error | 11242.1T | |
R-Squared | 0.49 | |
Significance | 0 | |
Slope | 22,586,057 | |
Total Sum of Squares | 288984.3T |
Arrowhead Net Tangible Assets History
About Arrowhead Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Arrowhead Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Arrowhead Pharmaceuticals investors use historical funamental indicators, such as Arrowhead Pharmaceuticals's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Arrowhead Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Arrowhead Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arrowhead Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Arrowhead Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Arrowhead Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Net Tangible Assets | 300.2 M | 202.9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Arrowhead Pharmaceuticals Correlation against competitors. To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Arrowhead Stock analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stocks Directory Find actively traded stocks across global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.098 | Earnings Share (4.23) | Revenue Per Share 0.319 | Quarterly Revenue Growth (0.94) | Return On Assets (0.32) |
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.